NCT05970120View on ClinicalTrials.gov

A Study of Intracardiac Ultrasound With the NUVISION NAV Ultrasound Catheter

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 5, 2023

Primary Completion Date

February 22, 2024

Study Completion Date

February 22, 2024

Conditions
Scar-related Atrial TachycardiaPersistent Atrial FibrillationParoxysmal Atrial FibrillationVentricular TachycardiaPremature Ventricular Complex
Interventions
DEVICE

NUVISION NAV Ultrasound Catheter

Participants will be scheduled to have a clinically-indicated ablation procedure using NUVISION NAV ultrasound catheter for management of atrial procedure.

Trial Locations (3)

20138

Centro Cardiologico Monzino, Milan

21000

KBC Split, Split

7033001

Yitzhak Shamir Medical Center, Ẕerifin

All Listed Sponsors
lead

Biosense Webster, Inc.

INDUSTRY

NCT05970120 - A Study of Intracardiac Ultrasound With the NUVISION NAV Ultrasound Catheter | Biotech Hunter | Biotech Hunter